Oruka's mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom ...

Continued to advance three clinical programs in immune-mediated diseases: The Phase 3 ONWARD program for ESK-001 in moderate-to-severe plaque psoriasis consists of two ... of risks and uncertainties ...

Lack of compatibility is the top reason for new couples to divorce, with 59% of couples who divorced in their first year citing this cause. A total of 689,308 divorces occurred in 2021 and ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Researchers have developed a patch for easier and more effective treatment of psoriasis. The method may also be used in treatment of other inflammatory skin diseases.

Frailty and functional dependency affect treatment satisfaction and may require tailored care for older adults with psoriasis ...

"This is the first time I'm really talking about it publicly… but you just get that 'aha' moment where you realize 'I wasn't put in this position to not utilize my voice and my platform for good." La ...

Top line results for the Phase 3 ICONIC-LEAD and ICONIC-TOTAL studies 2 in moderate to severe plaque psoriasis, are expected in Q4 2024. Top line results for the Phase 2b ANTHEM multicenter, ...

Medically reviewed by Casey Gallagher, MD Psoriasis of the hands and feet, known as palmoplantar psoriasis, is an inflammatory autoimmune disorder that causes scaly, itchy skin patches on the palms ...